Hjem › Amyloidose › Minnesota
Kliniske studier for Amyloidose i Minnesota
10 studier for Amyloidose søker deltakere på steder i Minnesota.
Byer i Minnesota
Offisiell studietekst (engelsk)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Rochester
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Rochester
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Rochester
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07223203Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Rochester, Rochester
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- GSK Investigational Site, Rochester
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. jul. 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Rochester
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Mayo Clinic - Rochester /ID# 255258, Rochester
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Mayo Clinic, Rochester
RekruttererFase 3
Alder 18 til 90 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06128629A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
- Mayo Clinic, Rochester
RekruttererObservasjonsstudie
Alder 20 og eldre · Alle kjønn · Oppdatert 26. des. 2025 · NCT07216469A Study Of MCG In Cardiac Amyloidosis
- Mayo Clinic in Rochester, Rochester
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 22. des. 2025 · NCT07218705Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.